APA (7th ed.) Citation

Truitt, K. E., Daveson, A. J. M., Ee, H. C., Goel, G., MacDougall, J., Neff, K., & Anderson, R. P. (2019). Randomised clinical trial: A placebo‐controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease. Alimentary Pharmacology & Therapeutics, 50(5), 547. https://doi.org/10.1111/apt.15435

Chicago Style (17th ed.) Citation

Truitt, Kenneth E., A. James M. Daveson, Hooi C. Ee, Gautam Goel, James MacDougall, Kristin Neff, and Robert P. Anderson. "Randomised Clinical Trial: A Placebo‐controlled Study of Subcutaneous or Intradermal NEXVAX2, an Investigational Immunomodulatory Peptide Therapy for Coeliac Disease." Alimentary Pharmacology & Therapeutics 50, no. 5 (2019): 547. https://doi.org/10.1111/apt.15435.

MLA (9th ed.) Citation

Truitt, Kenneth E., et al. "Randomised Clinical Trial: A Placebo‐controlled Study of Subcutaneous or Intradermal NEXVAX2, an Investigational Immunomodulatory Peptide Therapy for Coeliac Disease." Alimentary Pharmacology & Therapeutics, vol. 50, no. 5, 2019, p. 547, https://doi.org/10.1111/apt.15435.